PCM
PRVL

Pentwater Capital Management’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Pentwater Capital Management’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-17,694
Closed -$408K – 357
2020
Q4 		$408K Buy
+17,694
New +$408K ﹤0.01% 165